NewsRx

Search our medical news database

ACE Inhibitors

ACE-inhibitory peptides were isolated from soybean protein hydrolysates

Published in Medical Devices and Surgical Technology Week, May 22nd, 2005

A recent report describes production of angiotensin I-converting enzyme inhibitory peptides from soybean protein with Monascus purpureus acid proteinase.

According to the report from Japan, "Soybean proteins, beta-conglycinin and glycinin were hydrolyzed by an acid proteinase from Monascus purpureus.

M. Kuba and colleagues of the University of the Ryukyus explained, "The degree of hydrolysis and inhibitory activities of angiotensin I-converting enzyme (ACE) increased with increasing proteolysis time. After 10 hours of incubation, the IC50 values of the beta-conglycinin and glycinin hydrolysates were determined, as 0.126...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook